Advanced Prostate Cancer

The standard set

The ICHOM Standard Set for Advanced Prostate Cancer is the result of hard work by a group of leading physicians, measurement experts and patients. It is our recommendation of the outcomes that matter most to patients with Advanced Prostate Cancer. We urge all providers around the world to start measuring these outcomes to better understand how to improve the lives of their patients.

1 Recorded via the Common Terminology Criteria for Adverse Events (CTCAE), version 4.0

2 Recorded via the Eastern Cooperative Oncology Group (ECOG) score

3 Includes pain-related quality of life and need for pain medication

4 Includes urinary incontinence, urinary frequency, urinary obstruction, urinary irritation, and bowel irritation

5 Includes hormonal symptoms

6 Recommended to track via the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)

7 Recommended to track via the Expanded Prostate Cancer Index Composite (EPIC-26)

8 Includes symptomatic skeletal related event, time to metastasis, castration resistant disease, and procedures needed for local progression


Standard Set materials have moved to ICHOM Connect and are still available free of charge. Please log in or register to gain access to unlimited ICHOM resources at a single click of a button. There, you can also indicate your interest in receiving updates about and implementing the Standard Set.

Available materials:

  • Flyer – a brief overview of the most important outcomes for patients relating to this ICHOM Standard Set.
  • Reference Guide – a complete overview of the ICHOM Standard Set, including definitions for each measure and selected PROM instruments, time points for collection, and associated risk factors.
  • Data Dictionary – an index of the outcomes and case-mix variables included in the standard set, how to code them, and the information you need to collect when implementing the outcomes in practice.
  • Press Release
  • Published Articles
  • Additional materials

Team that developed this standard


Ian Davis | Monash University; Eastern Health Clinical School
Susan Evans | Monash University
Ian Roos* | Cancer Action Victoria


Louis Denis* | Oncology Center Antwerp, US TOO Belgium
Bertrand Tombal | Cliniques Universitaires Saint Luc, Université Catholique de Louvain


Neil Fleshner | University of Toronto
Andrew Matthew | University of Toronto


Alberto Bossi | Gustave Roussy Cancer Institute


Thomas Steuber | University Hospital Hamburg-Eppendorf


Ray McDermott | St. Vincent’s University Hospital


Theo de Reijke | Academic Medical Center Amsterdam
Jean-Paul van Basten | Canisius Wilhelmina Hospital
Koos van der Hoeven | Leiden University Medical Center

United Kingdom

Heather Payne | University College Hospitals London

United States

Janet Abrahm | Dana-Farber Cancer Institute
Ethan Basch | University of North Carolina at Chapel Hill
Justin Bekelman | University of Pennsylvania
Donna Berry | Dana-Farber Cancer Institute
Daniel George | Duke University Medical Center
Jim Kiefert* | US TOO
Daniel Lin | University of Washington
Alicia Morgans | Vanderbilt University Medical Center
David Penson | Vanderbilt University Medical Center
Deborah Schrag | Dana-Farber Cancer Institute

* Patient representative

Stay up to date

To receive updates about this standard set, including new versions, please click on the box below.

View more standard sets

Atrial Fibrillation Image

Atrial Fibrillation

Cardiovascular and circulatory

ICHOM Sets of Patient-Centered Outcome Measures Diabetes Image


Diabetes, blood, and endocrine

Paediatric Facial Palsy

Congenital anomalies

Congenital Upper Limb Anomalies

Congenital anomalies